Politico December 19, 2025
David Lim, Cheyenne Haslett

The President said more deals would be announced next week, and suggested White House pressure will also come to bear on health insurers soon.

Earlier this month, a top Republican pollster advised President Trump to promote his “affordability” bonafides — under attack by Democrats — by leaning into his efforts to lower prescription drug prices.

On Friday, the White House may have taken the tip. It announced deals with nine global pharmaceutical manufacturers, far more than in similar press conferences over the last several months.

“This represents the greatest victory for patient affordability in the history of American health care, by far,” Trump said at a press conference.

The deals, which have been in the works for the past few...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Federal Discretionary Spending To Address Substance Use Disorders: How Big A Shift?
White House and Congress Turn Focus to Health Policy
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
OIG Recounts Historic Recovery Numbers in Its Latest Semiannual Report to Congress
What is included in Trump’s “Great Healthcare Plan”?

Share Article